KISQALI

Identification of Kisqali

No description

Google image searchProduct monograph

Active ingredient

ribociclib (ribociclib succinate), 200 MG

DIN: 02473569

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 27-APR-2018

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EF — Cyclin-dependent kinase (CDK) inhibitors (ATC, ATC/DDD)
• L01EF02 — RIBOCICLIB (ATC/DDD)

Reference brand drug: Kisqali

External Links for Kisqali

Search on Google

• Kisqali side effects
• Kisqali dosage
• ribociclib side effects
• ribociclib dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find kisqali photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.